TransAct Technologies (TACT) CFO sells 1,000 shares at $4.30
TransAct Technologies Inc. (TACT) officer Steven A. DeMartino, who serves as President, CFO, Treasurer and Secretary, reported a stock transaction involving company shares.
Rhea-AI Filing Summary
TransAct Technologies Inc. (TACT) officer Steven A. DeMartino, who serves as President, CFO, Treasurer and Secretary, reported a stock transaction involving company shares. On 11/17/2025, he sold 1,000 shares of TransAct common stock at a price of $4.30 per share. After this transaction, he directly owned 148,847 shares of TransAct common stock.
The filing also notes that an additional 1,000 shares owned by Mr. DeMartino had been inadvertently omitted from his prior filings due to an administrative error, and this report reflects that correction.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,000 | $4.30 | $4K |
Footnotes (1)
- F1. Reflects an additional 1,000 shares owned by Mr. DeMartino, which were inadvertently omitted from his prior Form 4 filings due to an administrative error.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did TransAct Technologies (TACT) report for Steven A. DeMartino?
Steven A. DeMartino reported selling 1,000 shares of TransAct Technologies common stock on 11/17/2025 at a price of $4.30 per share.
What is Steven A. DeMartino’s role at TransAct Technologies (TACT)?
Steven A. DeMartino is an officer of TransAct Technologies, serving as President, Chief Financial Officer, Treasurer and Secretary.
When did the reported TransAct Technologies (TACT) insider transaction occur?
The reported transaction occurred on 11/17/2025, as shown in the Form 4 filing.
Is the reported TransAct Technologies (TACT) insider transaction a direct or indirect holding?
The Form 4 shows that Steven A. DeMartino’s 148,847 shares following the transaction are held with direct (D) ownership.
AI-generated analysis. How Rhea-AI works. Not financial advice.